Viewing Study NCT03445169


Ignite Creation Date: 2025-12-24 @ 10:53 PM
Ignite Modification Date: 2025-12-25 @ 8:22 PM
Study NCT ID: NCT03445169
Status: COMPLETED
Last Update Posted: 2020-11-09
First Post: 2018-02-20
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Food Effect Study in Healthy Volunteers With Belzutifan (PT2977, MK-6482) Tablets
Sponsor: Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module